Ewa Leporowska

Dr. Ewa Leporowska

Laboratory Departament, Greater Poland Cancer Center, Poznań, Wielkopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Katarzyna HojanKatarzyna Hojan
Katarzyna Hojan
DPDanuta Procyk
Danuta Procyk
DHDorota Horyńska-Kęstowicz
Dorota Horyńska-Kęstowicz
ELEwa Leporowska
Ewa Leporowska
MLMaria Litwiniuk
Maria Litwiniuk
Cardiotoxicity is known as a severe clinical problem in oncological practice that reduces the options for cancer therapy. Physical exercise is recognized as a well-established protective measure for many heart and cancer diseases. In our study, we hypothesized that supervised and moderate-intensity exercise training would prevent heart failure and its consequences induced by trastuzumab therapy. The aim of this study was to examine the effect of physical training on ventricular remodeling, serum cardiac markers, and exercise performance in women with human epidermal growth receptor 2 (HER2+) breast cancer (BC) undergoing trastuzumab therapy. This was a prospective, randomized, clinical controlled trial. Forty-six BC women were randomized into either an intervention group (IG) or a control group (CG). An exercise program (IG) was performed after 3–6 months of trastuzumab therapy at 5 d/week (to 80% maximum heart rate (HRmax)) for 9 weeks. We then evaluated their cardiac function using echocardiography, a 6-Minute Walk Test (6MWT), and plasma parameters (C-reactive protein (CRP), myoglobin (MYO), interleukin-6 (IL-6), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and creatine kinase (CK)). After the physical training program, we did not observe any significant changes in the left ventricular (LV) ejection fraction (LVEF) and 6MWT (p > 0.05) in the IG compared to the CG (decrease p < 0.05). The differences in the blood parameters were not significant (p < 0.05). To conclude, moderate-intensity exercise training prevented a decrease in the LVEF and physical capacity during trastuzumab therapy in HER2+ BC. Further research is needed to validate our results.

1 July 2019 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
AŁAgnieszka Łupicka-Słowik
Agnieszka Łupicka-Słowik
RGRenata Grzywa
Renata Grzywa
ELEwa Leporowska
Ewa Leporowska
DPDanuta Procyk
Danuta Procyk
JOJózef Oleksyszyn
Józef Oleksyszyn
MSMarcin Sieńczyk
Marcin Sieńczyk
Łupicka-Słowik A, et al. Ann Lab Med. 2019 Jul;39(4):373-380. https://doi.org/10.3343/alm.2019.39.4.373

10 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JGJoanna Grupińska
Joanna Grupińska
MBMagdalena Budzyń
Magdalena Budzyń
KMKalina Maćkowiak
Kalina Maćkowiak
JBJacek Jakub Brzeziński
Jacek Jakub Brzeziński
WKWitold Kycler
Witold Kycler
Dorota FormanowiczDorota Formanowicz
Dorota Formanowicz
Aim: Recently, more attention has been paid to the role of nutritional intervention in preventing the side effects of chemotherapy in oncology patients. Therefore, the aim of the present study was to analyze the effects of oral nutritional supplements on the body composition and biochemical parameters in women with breast cancer receiving postoperative adjuvant chemotherapy. Patients and Methods: The study involved women diagnosed with breast cancer who underwent surgical treatment and were qualified for chemotherapy (doxorubicin and cyclophosphamide). Women were divided into two groups, depending on whether oral nutritional supplements were used during chemotherapy. Anthropometric and biochemical parameters were analyzed twice in all patients: before and after six weeks of chemotherapy. Propensity score (PS) matching was performed to select patients balanced in terms of age, BMI, and clinicopathological features of the tumor. Statistical comparisons were conducted in a propensity-matched cohort of patients. Results: The value of BMI was maintained constant in the supplemented women older than 56 years after six weeks of chemotherapy. Regardless of age in the supplemented women, a significant increase in muscle mass, fat free mass (FFM), and fat free mass index (FFMI) was demonstrated. An increase in fat mass (FM) including visceral fat was observed only in the non-supplemented control. Regardless of age or initial FM, supplemented women exhibited a constant level of albumin. Moreover, in the supplemented women with normal initial FM, the stable values of triglycerides and HDL cholesterol were maintained after six weeks of chemotherapy. Conclusion: The present study demonstrated that oral nutritional supplements could improve body composition and prevent hypoalbuminemia and lipid abnormalities in women with breast cancer undergoing chemotherapy.

26 March 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
TKTomasz Kolenda
Tomasz Kolenda
PBPiotr Bialas
Piotr Bialas
KGKacper Guglas
Kacper Guglas
MSMaciej Karol Stasiak
Maciej Karol Stasiak
JKJoanna Kozłowska-Masłoń
Joanna Kozłowska-Masłoń
ATAnna Teresiak
Anna Teresiak
Background: High-risk human papillomavirus (HPV) contributes to oropharyngeal cancers through mechanisms involving the deregulation of host cell functions by oncoproteins E6 and E7. Changes in the epigenome, particularly involving long non-coding RNAs (lncRNAs), are crucial for understanding HPV-related carcinogenesis. Methods: This study aimed to analyze the expression levels of lncRNAs in HPV-related head and neck squamous cell carcinoma (HNSCC) to determine their biological and clinical significance, addressing the current gap in clinically validated biomarkers for early screening and therapeutic interventions. Results: The study highlights the significant overexpression of the EGOT gene in HPV-positive HNSCC samples, suggesting its potential as a marker to distinguish between HPV-negative and HPV-positive cases. Furthermore, high EGOT expression correlates with better overall survival (OS) and indicates possible resistance to therapy, making it a valuable prognostic factor. Conclusions: These findings underscore the potential of incorporating EGOT expression analysis in clinical practice for improved patient stratification and treatment outcomes in HNSCC.

22 February 2024 in Advances in Medical Sciences
Verified
Journal Article
Closed access
JGJoanna Grupińska
Joanna Grupińska
MBMagdalena Budzyń
Magdalena Budzyń
JJJakub Janowski
Jakub Janowski
JBJacek Brzeziński
Jacek Brzeziński
BGBogna Gryszczyńska
Bogna Gryszczyńska
WKWitold Kycler
Witold Kycler

31 January 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Katarzyna HojanKatarzyna Hojan
Katarzyna Hojan
KAKrystyna Adamska
Krystyna Adamska
ALAgnieszka Lewandowska
Agnieszka Lewandowska
DPDanuta Procyk
Danuta Procyk
ELEwa Leporowska
Ewa Leporowska
SMSlawomir Michalak
Slawomir Michalak
Radiotherapy (RT) plays a key role in brain tumours but can negatively impact functional outcomes and quality of life. The aim of this study was to analyse anti-neural and onconeural autoantibodies and markers of blood–brain barrier (BBB) disruption in patients with primary brain cancer undergoing RT. Materials and methods. A prospective study was conducted on 45 patients with a brain tumour scheduled for intensity-modulated radiotherapy. Assessments were performed at baseline, post-RT, and at three months. We measured serum levels of BBB disruption biomarkers and anti-neural, onconeural, and organ-specific antibodies. Results. Antibodies against nucleosome antigens and neuronal surface antigens were detected in 85% and 3% of cases, respectively; anti-neural and onconeural antibodies were observed in 47% and 5.8%. In 44% patients, ≥2 antibody types were detected. No significant changes in BBB biomarkers were observed. Conclusion. The findings of this study show that a humoral immune response is common in patients undergoing RT for brain cancer. This response appears to be non-organ specific but rather directed against nucleosome antigens, but onconeural antibodies were uncommon, suggesting a low risk of a neurological paraneoplastic syndrome. Our data suggested that radiotherapy may not affect BBB integrity, but larger studies are needed to better characterise the pathophysiological effects of RT.